FRANKLIN RESOURCES INC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 38777 San Mateo, CA

Position in FULC

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$419,288

-$81,167 QoQ

Shares Held

54,666

+23.5% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#70

of 168 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FRANKLIN RESOURCES INC holds $7,057,629,017 across 165 Biotechnology names. FULC ranks #142 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,722,071	$2,103,180,930
2	ASND	Ascendis Pharma A/S	2,051,948	$469,342,063
3	INSM	INSMED Inc	2,617,251	$427,972,880
4	JAZZ	Jazz Pharmaceuticals plc	1,958,940	$370,337,604
5	VRTX	Vertex Pharmaceuticals Inc / Ma	551,132	$246,102,477
6	BBIO	BridgeBio Pharma, Inc.	2,438,925	$181,114,568
7	ARGX	Argenx SE	233,493	$170,508,261
8	ALNY	Alnylam Pharmaceuticals, Inc.	470,390	$155,637,935

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$419,288	54,666	+23.5%	Shares	Defined	2026-05-13
2025-12-31	$500,455	44,249	-26.3%	Shares	Defined	2026-02-11
2025-09-30	$552,202	60,022	0.0%	Shares	Defined	2025-11-13
2025-06-30	$412,950	60,022	+141.8%	Shares	Defined	2025-08-12
2025-03-31	$71,484	24,821	0.0%	Shares	Defined	2025-05-13
2024-12-31	$116,658	24,821	0.0%	Shares	Defined	2025-02-12
2024-09-30	$88,610	24,821	0.0%	Shares	Defined	2024-11-27
2024-06-30	$153,890	24,821	0.0%	Shares	Defined	2024-08-14
2024-03-31	$234,310	24,821	0.0%	Shares	Defined	2024-05-13
2023-12-31	$167,541	24,821	-12.5%	Shares	Defined	2024-02-09
2023-09-30	$125,900	28,356	0.0%	Shares	Defined	2023-11-13
2023-06-30	$93,574	28,356	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.